Inside Information / Ad-hoc Announcements 2017
Here you find Inside Information according to Article 17 MAR / Ad-hoc messages of year 2017.
To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.
|June 30, 2017|
09:18 a.m. CEST
|Bayer expects negative earnings impact from its Brazilian Crop Science business||Download PDF collect (65 KB)|
|February 08, 2017|
04:35 p.m. CET
|Bayer: Phase III COMPASS study with Bayer’s Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint Early||Download PDF collect (66 KB)|
Investor News issued in year 2017 can be found here.
Publications of the previous years are offered in the Archive Overview.